Ishara Investments LP
CIK 2111609 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $136.1M
- Posisi
- 41
- Per tanggal
- 30 Juni 2026
#7.687 dari 9.443 berdasarkan nilai 13F · top 81.4%
Nilai portofolio QoQ: +28.9% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 50,98%
- Bobot 25 kepemilikan teratas
- 87,15%
- Posisi di atas 1%
- 30
- Jumlah posisi efektif
- 26,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 41,5% Perkiraan pembelian $67.332.881 · penjualan $50.153.102
- Posisi baru
- 16
- Meningkat
- 13
- Menurun
- 8
- Tertutup
- 11
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 94,0% · Opsi dikecualikan: 4,2%
Rincian sektor
Healthcare
100,0%
Portofolio lengkap 41 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $10.373.000 | 7,62% | 410.000 | $7.635.020 | Naik ×1 | ||
| XERS Xeris Biopharma Holdings, Inc. - Common Stock | $9.741.600 | 7,16% | 1.230.000 | $3.796.600 | Naik ×2 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $8.211.070 | 6,03% | 143.500 | $3.578.890 | Naik ×1 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $7.549.515 | 5,55% | 22.550 | $284.130 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $6.844.950 | 5,03% | 205.000 | $3.194.412 | Naik ×2 | ||
| AGIO Agios Pharmaceuticals, Inc. - Common Stock | $6.086.040 | 4,47% | 164.000 | ||||
| INSM Insmed Incorporated - Common Stock | $5.464.275 | 4,01% | 51.250 | ||||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $5.369.770 | 3,95% | 143.500 | Naik ×1 | |||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $4.971.250 | 3,65% | 1.025.000 | $2.093.050 | Turun ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $4.766.660 | 3,50% | 82.000 | $1.431.146 | Naik ×2 | ||
| ANNX Annexon, Inc. - common stock | $4.682.200 | 3,44% | 820.000 | $3.716.855 | Naik ×1 | ||
| TVTX Travere Therapeutics, Inc. - Common Stock | $4.658.420 | 3,42% | 82.000 | $1.369.523 | Turun ×1 | ||
| TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | $4.316.070 | 3,17% | 338.250 | Naik ×1 | |||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $4.275.152 | 3,14% | 57.400 | ||||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $4.014.228 | 2,95% | 16.400 | $-2.915.592 | Turun ×1 | ||
| CTNM Contineum Therapeutics, Inc. - Common stock | $3.359.950 | 2,47% | 205.000 | $1.505.430 | Naik ×1 | ||
| LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | $3.050.400 | 2,24% | 1.271.000 | $1.643.280 | Naik ×2 | ||
| KURA Kura Oncology, Inc. - Common Stock | $3.035.948 | 2,23% | 276.750 | Naik ×1 | |||
| DBVT DBV Technologies S.A. - American Depositary Shares | $3.025.800 | 2,22% | 184.500 | $884.575 | Naik ×1 | ||
| GMAB Genmab A/S - American Depositary Shares | $2.815.675 | 2,07% | 102.500 | $615.615 | Naik ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $2.794.232 | 2,05% | 32.800 | Naik ×1 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $2.765.450 | 2,03% | 102.500 | $544.070 | Naik ×1 | ||
| SLN Silence Therapeutics Plc - American Depository Share | $2.434.847 | 1,79% | 55.350 | $1.694.412 | Turun ×2 | ||
| NUVB Nuvation Bio Inc. Class A Common Stock | $2.095.920 | 1,54% | 369.000 | ||||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $1.905.680 | 1,40% | 328.000 | Naik ×1 | |||
| NKTR Nektar Therapeutics - Common Stock | $1.860.437 | 1,37% | 26.650 | ||||
| SRRK Scholar Rock Holding Corporation - Common Stock | $1.691.250 | 1,24% | 30.750 | $-1.130.534 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $1.664.600 | 1,22% | 32.800 | Naik ×1 | |||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $1.542.779 | 1,13% | 5.125 | $-152.930 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $1.407.120 | 1,03% | 41.000 | $39.278 | Turun ×1 | ||
| SION Sionna Therapeutics, Inc. - Common Stock | $1.350.540 | 0,99% | 123.000 | $-621.888 | Naik ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $1.332.090 | 0,98% | 123.000 | $33.415 | Naik ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $1.250.541 | 0,92% | 36.900 | $69.372 | |||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1.221.956 | 0,90% | 2.460 | Naik ×1 | |||
| SPRY ARS Pharmaceuticals, Inc. - Common Stock | $1.149.355 | 0,84% | 143.490 | Naik ×1 | |||
| MNPR Monopar Therapeutics Inc. - Common Stock | $1.138.857 | 0,84% | 12.300 | Naik ×1 | |||
| ERAS Erasca, Inc. - Common Stock | $751.120 | 0,55% | 41.000 | Naik ×1 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $439.828 | 0,32% | 10.250 | $-2.859.032 | Turun ×1 | ||
| IMTX Immatics N.V. - Ordinary Shares | $311.498 | 0,23% | 30.750 | $-1.201.402 | Turun ×1 | ||
| MREO Mereo BioPharma Group plc - American Depositary Shares | $244.232 | 0,18% | 768.750 | Naik ×1 | |||
| GOSS Gossamer Bio, Inc. - Common Stock | $134.972 | 0,10% | 820.000 | $-134.398 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| AGIO | $6.086.040 | 164.000 | 4,47% |
| INSM | $5.464.275 | 51.250 | 4,01% |
| CRNX | $5.369.770 | 143.500 | 3,95% |
| TNXP | $4.316.070 | 338.250 | 3,17% |
| BBIO | $4.275.152 | 57.400 | 3,14% |
| KURA | $3.035.948 | 276.750 | 2,23% |
| CYTK | $2.794.232 | 32.800 | 2,05% |
| NUVB | $2.095.920 | 369.000 | 1,54% |
| WVE | $1.905.680 | 328.000 | 1,40% |
| NKTR | $1.860.437 | 26.650 | 1,37% |
| ELVN | $1.664.600 | 32.800 | 1,22% |
| VRTX | $1.221.956 | 2.460 | 0,90% |
| SPRY | $1.149.355 | 143.490 | 0,84% |
| MNPR | $1.138.857 | 12.300 | 0,84% |
| ERAS | $751.120 | 41.000 | 0,55% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| ACAD | Beli lebih banyak | +287K | +$7.6M |
| XERS | Beli lebih banyak | +205K | +$3.8M |
| ANNX | Beli lebih banyak | +646K | +$3.7M |
| BMRN | Beli lebih banyak | +62K | +$3.6M |
| RARE | Beli lebih banyak | +31K | +$3.2M |
| AXSM | Dipangkas | -25K | -$2.9M |
| ZNTL | Dipangkas | -205K | +$2.1M |
| SLN | Dipangkas | -85K | +$1.7M |
| LXRX | Beli lebih banyak | +369K | +$1.6M |
| CTNM | Beli lebih banyak | +63K | +$1.5M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| KALV | 30 Juni 2026 | 276.750 | $5.570.978 | Tidak lagi dilacak |
| FOLD | 30 Juni 2026 | 369.000 | $5.335.740 | Tidak lagi dilacak |
| VSTM | 30 Juni 2026 | 820.000 | $4.346.000 | 81,9% |
| NUVB | 31 Maret 2026 | 400.000 | $3.584.000 | 62,8% |
| ARWR | 30 Juni 2026 | 55.350 | $3.470.445 | 8,2% |
| MLTX | 30 Juni 2026 | 174.250 | $3.248.020 | -18,5% |
| BBIO | 31 Maret 2026 | 36.000 | $2.753.640 | 11,3% |
| ARDX | 30 Juni 2026 | 451.000 | $2.701.490 | -22,4% |
| UTHR | 31 Maret 2026 | 5.500 | $2.679.875 | -11,3% |
| BCRX | 31 Maret 2026 | 300.000 | $2.340.000 | 3,1% |
| SNDX | 31 Maret 2026 | 100.000 | $2.101.000 | -15,2% |
| CPRX | 30 Juni 2026 | 82.000 | $2.030.320 | Tidak lagi dilacak |
| TARS | 31 Maret 2026 | 24.000 | $1.965.120 | 3,0% |
| APOG | 31 Maret 2026 | 25.000 | $1.887.000 | 26,0% |
| INSM | 31 Maret 2026 | 10.000 | $1.740.400 | -23,3% |
| LGND | 30 Juni 2026 | 8.200 | $1.637.130 | -8,5% |
| EWTX | 30 Juni 2026 | 49.200 | $1.549.800 | 8,0% |
| CORT | 31 Maret 2026 | 44.000 | $1.531.200 | 204,2% |
| APLS | 31 Maret 2026 | 50.000 | $1.256.000 | Tidak lagi dilacak |
| DNLI | 31 Maret 2026 | 70.000 | $1.155.700 | 31,0% |
| ASND | 31 Maret 2026 | 5.000 | $1.066.200 | 12,7% |
| BHVN | 31 Maret 2026 | 88.000 | $993.520 | 68,5% |
| DNTH | 31 Maret 2026 | 24.000 | $989.040 | 33,2% |
| NKTR | 31 Maret 2026 | 20.000 | $845.600 | 4,4% |
| IDYA | 30 Juni 2026 | 24.600 | $819.672 | 8,8% |
| AGIO | 31 Maret 2026 | 30.000 | $816.600 | -0,1% |
| IMVT | 31 Maret 2026 | 30.000 | $762.600 | 79,3% |
| OLMA | 31 Maret 2026 | 30.000 | $750.000 | -25,0% |
| PTCT | 30 Juni 2026 | 10.250 | $698.333 | -13,4% |
| ARQT | 31 Maret 2026 | 12.000 | $348.480 | 6,6% |